These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35246317)

  • 1. Homozygous Familial Hypercholesterolaemia International Clinical Collaboration (HICC) registry: Levelling up access to treatment urgently needed.
    Stock JK
    Atherosclerosis; 2022 Apr; 346():84-85. PubMed ID: 35246317
    [No Abstract]   [Full Text] [Related]  

  • 2. Homozygous familial hypercholesterolaemia: shedding new light on a rare but deadly condition.
    Banach M; Penson PE
    Eur J Prev Cardiol; 2022 May; 29(5):815-816. PubMed ID: 35157033
    [No Abstract]   [Full Text] [Related]  

  • 3. LDL-C-Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes.
    Santos RD; Cuchel M
    Circulation; 2024 Jan; 149(5):363-366. PubMed ID: 38285739
    [No Abstract]   [Full Text] [Related]  

  • 4. First insights from the EAS familial hypercholesterolaemia collaboration registry: FH is still underdiagnosed and undertreated.
    Stock J
    Atherosclerosis; 2019 Nov; 290():138-139. PubMed ID: 31610884
    [No Abstract]   [Full Text] [Related]  

  • 5. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
    EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
    Lancet; 2021 Nov; 398(10312):1713-1725. PubMed ID: 34506743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia.
    Pirillo A; Catapano AL
    Eur J Prev Cardiol; 2022 May; 29(5):829-831. PubMed ID: 35148370
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
    ; Vallejo-Vaz AJ; De Marco M; Stevens CAT; Akram A; Freiberger T; Hovingh GK; Kastelein JJP; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Al-Khnifsawi M; AlKindi FA; Alnouri F; Alonso R; Al-Rasadi K; Al-Sarraf A; Ashavaid TF; Binder CJ; Bogsrud MP; Bourbon M; Bruckert E; Chlebus K; Corral P; Descamps O; Durst R; Ezhov M; Fras Z; Genest J; Groselj U; Harada-Shiba M; Kayikcioglu M; Lalic K; Lam CSP; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi HM; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Postadzhiyan A; Reda A; Reiner Ž; Sadoh WE; Sahebkar A; Shehab A; Shek AB; Stoll M; Su TC; Subramaniam T; Susekov AV; Symeonides P; Tilney M; Tomlinson B; Truong TH; Tselepis AD; Tybjærg-Hansen A; Vázquez-Cárdenas A; Viigimaa M; Vohnout B; Widén E; Yamashita S; Banach M; Gaita D; Jiang L; Nilsson L; Santos LE; Schunkert H; Tokgözoğlu L; Car J; Catapano AL; Ray KK;
    Atherosclerosis; 2018 Oct; 277():234-255. PubMed ID: 30270054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tuberous xanthomas as the first manifestation of homozygous familial hypercholesterolaemia].
    Hammami H; Benmously R; Marrak H; Debbiche A; Souissi A; Ayed MB; Fenniche S; Mokhtar I
    Ann Dermatol Venereol; 2008 Dec; 135(12):892-4. PubMed ID: 19084711
    [No Abstract]   [Full Text] [Related]  

  • 9. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
    ; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
    Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe familial hypercholesterolaemia: current and future management.
    Farnier M; Bruckert E
    Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic principles of food related problems--familial hypercholesterolaemia].
    Floré M; Robberecht N; Hermans H
    J Pharm Belg; 2012 Mar; (1):18-21. PubMed ID: 22536679
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
    Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN
    Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypercholesterolaemia: clinical features and management.
    Pottle A
    Nurs Stand; 2005 Dec 14-2006 Jan 3; 20(14-16):55-65; quiz 66. PubMed ID: 16372559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introducing Personalized Medicine Into Pediatric Homozygous Familial Hypercholesterolemia Care.
    Gidding SS; Hegele RA
    Arterioscler Thromb Vasc Biol; 2022 Dec; 42(12):1458-1460. PubMed ID: 36325896
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan D;
    Heart Lung Circ; 2007 Feb; 16(1):25-7. PubMed ID: 17188936
    [No Abstract]   [Full Text] [Related]  

  • 16. LOWER, a registry of lomitapide-treated patients with homozygous familial hypercholesterolemia: Rationale and design.
    Blom DJ; Fayad ZA; Kastelein JJ; Larrey D; Makris L; Schwamlein C; Bloeden L; Underberg J;
    J Clin Lipidol; 2016; 10(2):273-82. PubMed ID: 27055957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia.
    Sullivan DR; Hamilton-Craig I; van Bockxmeer F; Watts GF;
    Heart Lung Circ; 2012 Mar; 21(3):159-62. PubMed ID: 22364837
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial hypercholesterolaemia in Australia: new insights and developments.
    Hamilton-Craig IR; Watts GF
    Med J Aust; 2013 Feb; 198(2):72-3. PubMed ID: 23373481
    [No Abstract]   [Full Text] [Related]  

  • 19. Global Familial Hypercholesterolaemia Studies Collaboration (FHSC).
    Stock JK
    Atherosclerosis; 2021 Nov; 337():57-58. PubMed ID: 34686380
    [No Abstract]   [Full Text] [Related]  

  • 20. To be or not to be resilient in familial hypercholesterolaemia: implications for the management.
    Mercuro G; Cadeddu Dessalvi C; Deidda M
    Eur J Prev Cardiol; 2022 May; 29(5):793-794. PubMed ID: 34864958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.